Rolipram is a selective phosphodiesterase-4 inhibitor discovered and developed by Schering AG as a potential antidepressant drug in the early 1990s. It...
7 KB (542 words) - 18:38, 8 December 2023
cells in the central nervous system. The prototypical PDE4 inhibitor is rolipram. PDE4 inhibitors are known to possess procognitive (including long term...
18 KB (1,887 words) - 15:50, 2 October 2024
phosphodiesterase. Mesembrenone, an alkaloid from the herb Sceletium tortuosum Rolipram, used as investigative tool in pharmacological research Ibudilast, a neuroprotective...
22 KB (2,350 words) - 08:18, 3 June 2024
administration of rolipram, a PDE4 inhibitor, can increase cAMP levels in neurons after spinal cord injury. This is partially possible because rolipram is sufficiently...
24 KB (2,962 words) - 15:40, 7 June 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
202 KB (20,204 words) - 14:52, 11 October 2024
studies have found that phosphodiesterase 4 (PDE4) inhibitors, such as Rolipram, cause emesis as one of their side effects. It has been found that these...
17 KB (2,454 words) - 12:02, 23 August 2024
to pass in a variety of fields (e.g. sildenafil as a PDE5 inhibitor and Rolipram as a PDE4 inhibitor). The PDE nomenclature signifies the PDE family with...
15 KB (1,725 words) - 08:12, 7 August 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
35 KB (3,239 words) - 19:23, 3 October 2024
emotional memory. PDE4A inhibition is a target of a number of drugs including: rolipram (antidepressant and antiinflammatory) and cilomilast (antiinflammatory)...
11 KB (1,373 words) - 20:18, 2 September 2024
Proxyphylline Pumafentrine Quazinone Quazodine Revamilast Revizinone Roflumilast Rolipram Ronomilast Saterinone Senazodan Siguazodan Tetomilast Tofimilast Trapidil...
2 KB (137 words) - 00:17, 9 February 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
19 KB (1,818 words) - 06:09, 19 May 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
83 KB (7,403 words) - 19:22, 3 October 2024
pathways such as TNF alpha inhibition, since potent TNF inhibitors including rolipram and pentoxifylline do not inhibit myeloma cell growth or angiogenesis....
18 KB (1,273 words) - 10:05, 17 June 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
24 KB (2,290 words) - 12:21, 26 September 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
18 KB (1,729 words) - 10:07, 2 June 2024
may refer to: Datumetine Homatropine Methylenedioxypyrovalerone (MDPV) Rolipram This set index page lists chemical structure articles associated with the...
343 bytes (58 words) - 14:32, 10 March 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
15 KB (1,490 words) - 04:22, 18 September 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
9 KB (733 words) - 06:09, 9 February 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
22 KB (1,843 words) - 00:41, 7 October 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
10 KB (814 words) - 04:38, 1 August 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
24 KB (2,124 words) - 10:05, 18 August 2024
rolgamidine (INN) rolicyclidine (INN) rolicyprine (INN) rolipoltide (INN) rolipram (INN) rolitetracycline (INN) rolodine (INN) Rolofylline (USAN) rolziracetam...
13 KB (584 words) - 06:16, 21 September 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
8 KB (518 words) - 22:24, 7 January 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
14 KB (1,266 words) - 16:40, 23 September 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
5 KB (274 words) - 20:26, 23 September 2024
not related to TNF-α inhibition since potent TNF-α inhibitors such as rolipram and pentoxifylline did not inhibit myeloma cell growth nor angiogenesis...
49 KB (5,487 words) - 11:41, 24 January 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
14 KB (1,256 words) - 18:30, 10 December 2023
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
16 KB (1,723 words) - 17:39, 13 September 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
18 KB (1,570 words) - 05:29, 12 May 2024
Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine PDE5...
10 KB (877 words) - 22:57, 30 March 2024